chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Body pain; confusion; weakness; Mild fever; chills; headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (Body pain), CONFUSIONAL STATE (confusion), ASTHENIA (weakness), PYREXIA (Mild fever) and CHILLS (chills) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN (Body pain), CONFUSIONAL STATE (confusion), ASTHENIA (weakness), PYREXIA (Mild fever), CHILLS (chills) and HEADACHE (headache). At the time of the report, PAIN (Body pain), CONFUSIONAL STATE (confusion), ASTHENIA (weakness), PYREXIA (Mild fever), CHILLS (chills) and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
not getting high enough IG and requiring boosting as they get sick; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A patient (no qualifiers provided) received pneumococcal 13-val conj vac (dipht CRM197 protein) (PREVNAR 13), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "not getting high enough IG and requiring boosting as they get sick".  Additional information: Some kids [5 over the last few years] not getting high enough IG and requiring boosting as they get sick.  The information on the batch/lot number for pneumococcal 13-val conj vac (dipht CRM197 protein) has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300092588 same drug and event with different patient.;
Information has been received from a licensed practical nurse concerning a male (approximately 4 years of age to 15 years of age) who on 01-AUG-2007 was vaccinated with ZOSTAVAX (lot # 657558/0461U) instead of varicella virus vaccine live (MSD). Subsequently, no adverse experiences have been reported. Unspecified medical attention was sought. The nurse reported in follow-up thath the packaging for the ZOSTAVAX and Varicella virus live (MSD) was similar and the 2 vaccines were stored in the same freezer. The Varicella virus vaccine live (MSD) had run out and the ZOSTAVAX picked up mistakenly. The nurse hoped to avoid this event in the future. There have been positive results noted from the parents of the vaccinated child.This is one of several reports received from the same source. Additional information is not expected.
My arm hurt immediately after getting the flu shot. But I didn't think anything right away as this is typical. The next day it was still bad and didn't go away. It hurt near the shoulder, a sharp pain when I would move  my arm in most directions. Simple things like releasing the parking brake in the car by my knee, pulling a blanket over me in bed. Lifting light things. Opening a door. Everything. I rested it a few days to little but not much improvement. Then things around it started hurting because I wasn't using it and had it glued to my side. My back started freezing up. I was able to treat my back and the things around it with 2 visits to massage therapist specializing in fixing problems. But the shoulder never improved. Still sharp pain from most day to day arm activities with no improvemnt and increasing worry. I finally started in physical therapy after 5 weeks (10/25/19)and I started improving immediately from the strengthening and movement exercises he gave me. These were exercises for shoulder impingement. Bursitis may also describe what I have. I have made consistent progress but it has been a long process. It has been 6 weeks of twice daily physical therapy exercises and icing at home (with 3 PT visits to monitor and increase exercises 10/25, 11/7, 11/22) and now I am able to use my arm more. I still get twinges from most movements and pain (much less than before) from various movements and still have only limited weight-bearing capacity but I continue to do the exercises and go to PT.  Both the doctor and physical therapist asked extensively about other possible causes when I indicated it was due to a flu shot. I said there was no hurt or trauma event and then I've had zero history of shoulder issues and it happens immediately following the flu shot It seems to fit SIRVA shoulder injury related to vaccine administration. My weight and smaller arm muscle mass seem to fit descriptions where the injection can go in too deep and hit the Bursa sack or something else.
Eyes burning as though excess salt is being expelled through eyes and tear ducts.  Never had this happen before being vaccinated. Occurs daily.
Intractable nausea and vomiting. Severe taste of kerosine in mouth.  Nosebleeds .
Starting on 1/31/21 patient was very fatigued and continued to worsen until today (2/3/21) where the patient's son called 911. The patient was in a complete haze and very foggy. The pt would not open her eyes or respond when her son would ask her any questions. EMS arrived and did not take her to hospital. Stayed with her in the home for awhile and waited for recovery. EMS had her eating and drinking until she would open her eyes. They advised son to continue to give her liquids to continue recovery.
central retinal artery occlusion; Information has been received from a lawyer referring to a female patient of unknown age. Information about concurrent condition, history condition and concomitant medication was not reported. On or around 27-DEC-2017, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, route, lot# and expiration date unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving zoster vaccine live (ZOSTAVAX), the patient suffered sudden blurred vision in her right eye and was diagnosed with central retinal artery occlusion. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using the vaccine. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live (ZOSTAVAX), the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the event central retinal artery occlusion was considered to be not recovered and causal relationship was assessed as related.   The lawyer considered the events central retinal artery occlusion to be disability.  Upon internal review, central retinal artery occlusion was determined to be medically significant.
I received my first Moderna shot on 6 March 2021, and my second shot on 9 April 2021. My May period (3-6 May) was largely normal, although I had bad cramps. On 19 May I had terrible cramps and breakthrough bleeding. On June 19-21 I had terrible cramps and swollen breasts, but passed no blood, only small rubbery black clots. In July I had no period at all, although I had cramps and passed black rubbery clots with no blood on 19 July. Had a largely normal but only 2 day long period on August 1-2.  Had a normal period on 25-29 August.
Information has been received from a registered nurse referring to an unknown number of unspecified patients of unknown ages and genders. The patients' medical histories and concurrent conditions were not reported. On unknown dates in 2016 (reported as "unknown dates starting on or after 15-JAN-2016") the patients were administered with improperly stored doses of GARDASIL 9 (dose, route, lot# and expiration date not reported). The vaccine was improperly stored at 0 degrees for 90 hours. Data logger was not involved. There was no previous temperature excursion. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
a rash on her hand and side of her hand; swelling under her lips with bumpps; swelling under her lips with bumps; This is a spontaneous report received from a contactable consumer (patient). A 62-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on Tuesday 06Apr2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On Thursday (an unspecified date) the patient experienced a rash on her hand and side of her hand and swelling under her lips with bumps. The patient wanted to know if she should receive the second dose. The outcomes of rash, swelling, and bumps were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
has to pee every 5-10 minutes; neck ache; This spontaneous case was reported by a consumer and describes the occurrence of POLLAKIURIA (has to pee every 5-10 minutes) and NECK PAIN (neck ache) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced POLLAKIURIA (has to pee every 5-10 minutes) and NECK PAIN (neck ache). At the time of the report, POLLAKIURIA (has to pee every 5-10 minutes) and NECK PAIN (neck ache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient did not take medication to treat symptoms.  Patient reports taking cholesterol medication, drug name was provided.   Second dose is scheduled on 09Apr2021.
Woke up in the morning with petechial hemorrhages (pinpoint dots) from elbow down to fingertips only on right arm, which is the side of vaccination. Dull ache down arm is present. Joints are swollen more on right side.
Purpura; Inappropriate Schedule of Drug Administration; Rash Erythematous; Roseola; Rhinorrhea: Urticaria Information has been received from a physician concerning a 17 week old teething male with no other medical history and no known drug allergies (NKDA) who on 17-MAR-2006 was vaccinated P) with the first dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human-bovine) (Lot 653754/0139F). Concomitant vaccines administered on that same day included the second IM dose of hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine (OMPC) (MSD) (Lot #653524/1192R), the second IM dose of diphtheria toxoid (+) pertussis acellular 5-component vaccine +) tetanus toxoid (Daptacel ) (Lot #C239), the second IM dose of poliovirus vaccine inactivated (Verol) (IPOL) (Lot #Y0576) and the second IM dose of pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (CRM197) (Prevnar) (Lot #B08642). There was other concomitant therapy or illness at the time of vaccine. On 19-MAR-2006, the patient developed slightly purpuric rash characterized by bumps and little red spots that were slightly raised on both legs (from thighs down), hands, arms, (from elbow down) and torso which became urticarial. There was no itching or fever. On 21-MAR-2006, the patient was seen in the Emergency Room and was diagnosed with roseola. On 22-MAR-2006 the patient was seen by the physician as his rash persisted. At that time there was no blood in the stool. On 24-MAR-2006, the patient was again seen by the physician to re-check the rash on his hand. On 26-MAR-2006, the patient seen by another physician. At that time the patient had no fever, vomiting, diarrhea or difficulty breathing and appeared to be well hydrated. The patient was noted to have normal skin turgor, no lesions. He had a diffuse red pinpoint rash over his body with areas of hives and urticaria spread over the torso and extremities. The patient had more purple skin lesions and thicker areas of hives. No petechia or purpura was noted at that time. The patient was encouraged to rest and consume fluids. On 11-APR-2006, the patient's purpuric red rash and urticaria resolved.  Medical records also contained the following adverse event: running nose (March 2006). No further information is available.
administration of expired dose; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 17-year-old male patient who received Men B NVS (Bexsero) (batch number ABXB58AA, expiry date 30th September 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 5th October 2022, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 5th October 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 05-OCT-2022 Reporter's Comments: A nurse practitioner called to ask for information about the administration of an expired dose of Bexsero to a 17 years old patient.  The reporter asked for recommendation about patient re-vaccination.  The reporter was consented to follow up. Additional Supportive Information:  The vaccine was already expired and was administered to the patient, which led to expired vaccine used.
Low grade fever, chills, moderate fatigue, moderate muscle and skeletal aches, mild sinus congestion, and mild cough starting less than 12 hrs from vaccination. Progression of symptoms to only moderate fatigue and moderate sinus congestion with continuing mild cough at 36 hrs after vaccination. Sinus pressure & inflammation, congestion, headaches, and fatigue worsening from that point to day 6 after vaccination. On day 6 after vaccination, I took a rapid test for COVID and received a positive result.  Symptoms Improving now (late in day 6 after vaccination).
tingling in tongue; nausea; body aches; soreness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8730) via an unspecified route of administration in the left arm on 31Mar2021 at 12:00(at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included none. Concomitant medications included retinol (VITAMIN A), cetirizine hydrochloride (ZYRTEC) and paracetamol (TYLENOL) from an unknown date for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 16:00 the patient experienced soreness at injection site(vaccination site pain). On 02Apr2021 the patient experienced nausea and body aches(general body pain). On 03Apr2021 the patient experienced tingling in tongue. The patient did not receive any treatment for the events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event soreness at injection site, nausea, body aches and tingling in tongue was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
I was trying to vomit blood twice; Having a lot of pain in the site that I was taken in; both arms that began to hurt; my back began to hurt; Tiredness; Headache; Muscle pain; Chills; Joint pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 23Feb2022 (Lot number: FL3209) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Manufacturer Unknown), for Covid-19 Immunization; Covid-19 vaccine (Dose 2, Manufacturer Unknown), for Covid-19 Immunization. The following information was reported: HAEMATEMESIS (medically significant) with onset Feb2022, outcome "unknown", described as "I was trying to vomit blood twice"; VACCINATION SITE PAIN (non-serious) with onset Feb2022, outcome "unknown", described as "Having a lot of pain in the site that I was taken in"; PAIN IN EXTREMITY (non-serious) with onset Feb2022, outcome "unknown", described as "both arms that began to hurt"; BACK PAIN (non-serious) with onset Feb2022, outcome "unknown", described as "my back began to hurt"; FATIGUE (non-serious) with onset Feb2022, outcome "unknown", described as "Tiredness"; HEADACHE (non-serious) with onset Feb2022, outcome "unknown", described as "Headache"; MYALGIA (non-serious) with onset Feb2022, outcome "unknown", described as "Muscle pain"; CHILLS (non-serious) with onset Feb2022, outcome "unknown", described as "Chills"; ARTHRALGIA (non-serious) with onset Feb2022, outcome "unknown", described as "Joint pain". Clinical course: The patient stated that  was having a side effect from the (Pfizer Covid-19 Vaccine) that  patient had taken because was having a lot of pain in the site that patient was taken in. It was both arms that began to hurt and patient's back began to hurt and had been having tiredness, headache, muscle pain, chills and joint pain and occasionally and a couple of days ago patient was trying to vomit blood twice.Patient stated that patient had excruciating amount of pain and had been taking a lot of pain from it (vaccine) lately but don't have the pain always, it just off and on pain.  No follow-up attempts are possible. No further information is expected.
Face itchy, headache reported immediately after vaccination - improved after only few minutes and no treatment was necessary.  Upon follow up she denied having any further complications.
The patient came in today and claimed that he has chronic left shoulder pain and the pain started since he got the pneumovax vaccine in April. He said he came in the store and we recommended ibuprofen for him. He said he would need surgery for his left shoulder and in the process of getting one. He does not want any other vaccines now or in the future. Patient does not want anything from the store and patient does not want us to put a report in but we told him we have to because he came and told us the situation.    Spoke to staff at the office and to let MD know about the situation. Staff said he has left AC separation injury since June 2019 and there is no notes from the doctor that this is caused by getting the vaccine. Staff will letMD know.
Patient had shoulder pain following vaccine administration, started approximately one week after receiving vaccine. Came and talked with pharmacist on duty when it occurred and decided to wait to see if it was pain from administration and would go away with time. When talking with patient for second dose she stated pain never completely went away. Described the pain in her shoulder similar to a torn rotator cuff.
Tested positive for COVID 2 weeks ago, felt like had a bad cold and flu like symptoms; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Tested positive for COVID 2 weeks ago, felt like had a bad cold and flu like symptoms) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Oct-2022, the patient experienced COVID-19 (Tested positive for COVID 2 weeks ago, felt like had a bad cold and flu like symptoms). At the time of the report, COVID-19 (Tested positive for COVID 2 weeks ago, felt like had a bad cold and flu like symptoms) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Oct-2022, SARS-CoV-2 test: (Positive) Positive.  No concomitant medications were provided. Patient received all Moderna vaccines and tested positive for COVID 2 weeks ago, 10-Oct-2022, felt like he had a bad cold, flu like symptoms.  He did not take any medications. He inquired if he should take the Bivalent vaccine because he and his father will be traveling out of the country on 8-Nov-2022 for 3 months. This case was linked to US-MODERNATX, INC.-MOD-2022-664591 ( Linked Report).Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-664591:Father's case
Initially the injection redness area was about the size of a quarter. The circle of redness has expanded to almost her elbow and is very tender.
Patient required inpatient admission to hospital with COVID-19 on 10/2/2021 (presented with cough, shortness of breath, and sore throat for the past week per provider notes). As of 10/6/2021, the patient remains admitted to the hospital for treatment of COVID-19 infection.
Redness, warm to touch, itching sore (below injection site toward inner aspect (L) arm). Did not receive H1N1 in 2009. Has rec'd seasonal flu vaccine in the past.
Patient is a 23-year-old female with past medical history significant for epilepsy, presenting for four days of generalized arthralgias. Patient received the Johnson and Johnson COVID-19 vaccine on 5/6/2021. Two days later she was feeling well and did her usual workout. On 5/9, patient awoke with pain in all of her joints excluding her ankles. She has continued to experience these pains through today. This is abnormal for her as she is typically active. She has been taking Ibuprofen, Tylenol, and Flexeril without relief. She denies any fevers, chest pain, shortness of breath, nausea, vomiting, diarrhea, sore throat, or rashes. No prior similar experiences. Of note, patient had strep pharyngitis 4/6/2021, and she finished the prescribed course of antibiotics. She follows with Dr. from neurology. LMP unknown as patient has birth control implant. Denies vaginal bleeding or discharge. No past surgical history. Medications reviewed. Currently on Lamotrigine. Allergies noted. Patient is a nonsmoker, occasional drinker, uses marijuana recreationally. Family history includes hypertension and diabetes.
7/27/21 4:13 PM Note    PC from pt. She is at urgent care today with cough, HA, Ear pain, runny nose. Exposed to covid Friday and Sx started Sunday. Pt has both covid vaccines